Daiichi Sankyo
Global pharmaceutical company with a rich legacy of innovation to help patients. See our community guidelines: http://t.co/qlLpvGG2xS.
Enterprise value
$47.9b
Share price
JPY3556.00 4568.T
Recent deals
Notable known LPs
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
No items found
No investors found
| JPY | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 9 % | 22 % | 25 % | 18 % | 8 % | 13 % | 13 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 13 % | 16 % | 19 % | 23 % | 22 % | 22 % | 23 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 6 % | 9 % | 13 % | 16 % | 15 % | 16 % | 17 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 25 % | 27 % | 23 % | 23 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
exited
ACQUISITION by Daiichi Sankyo Feb 2011
ACQUISITION by Daiichi Sankyo Sep 2014
exited
ACQUISITION by Daiichi Sankyo May 2008
ACQUISITION by Daiichi Sankyo Oct 2015
exited
ACQUISITION by Daiichi Sankyo Apr 2006
ACQUISITION by Qol Holdings Oct 2023